Etilefrine: A Novel Treatment for Refractory, Life-Threatening Chylothorax in the Newborn.
Where this comes from
- Record sourced from PubMed, PMID 40664399.
- Also identified by DOI 10.1542/peds.2024-069683.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
There are few evidence-based treatment options for chylothorax in newborns. We report on 5 cases of preterm newborn infants who received drainage and continuous etilefrine infusion for clinically significant, refractory chylothorax. Irrespective of the cause of the effusion, etilefrine infusion was associated with a clear decrease in chylous output within 2 to 4 days of initiation with heart rates and blood pressures maintained within the age-normal limits.
Medical subject headings
- Chylothorax
- Infant, Premature, Diseases